We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

160 hedge funds and large institutions have $237M invested in TherapeuticsMD in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 62 increasing their positions, 27 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 27

66% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.54M

20% more capital invested

Capital invested by funds: $197M → $237M (+$39.9M)

13% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 24

1% more funds holding

Funds holding: 159 → 160 (+1)

0.17% less ownership

Funds ownership: 1.09% → 0.91% (-0.17%)

Holders
160
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
62
Reduced
27
Closed
24
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.01M
Net Calls Change
+$1.11M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.67M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.71M
3
State Street
State Street
Massachusetts
+$4.31M
4
PA
Perceptive Advisors
New York
+$4.31M
5
Millennium Management
Millennium Management
New York
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$7.24M
2
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
-$3.92M
3
Morgan Stanley
Morgan Stanley
New York
-$3.07M
4
RCMNY
Rubric Capital Management (New York)
New York
-$2.7M
5
HI
Handelsinvest Investeringsforvaltning
Denmark
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$1.56M +$1.49M +19,007 +444%
Swiss National Bank
27
Swiss National Bank
Switzerland
$1.12M +$438K +5,600 +50%
SM
28
Sabby Management
Florida
$1.07M +$1.25M +16,000 New
KOCAA
29
Knights of Columbus Asset Advisors
Connecticut
$945K – – –
JP Morgan Chase
30
JP Morgan Chase
New York
$887K -$18.9K -241 -2%
MWNA
31
Marshall Wace North America
New York
$810K -$471K -6,023 -33%
RJA
32
Raymond James & Associates
Florida
$703K +$15.4K +197 +2%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$682K +$186K +2,382 +31%
Two Sigma Investments
34
Two Sigma Investments
New York
$659K +$770K +9,837 New
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$643K – – –
GCP
36
GSA Capital Partners
United Kingdom
$637K +$141K +1,804 +23%
CSS
37
Cubist Systematic Strategies
Connecticut
$589K +$664K +8,488 +2,820%
TD Asset Management
38
TD Asset Management
Ontario, Canada
$582K – – –
VF
39
Virtu Financial
New York
$578K -$214K -2,738 -24%
TCM
40
Traynor Capital Management
Pennsylvania
$493K +$433K +5,530 +302%
JAM
41
Jupiter Asset Management
United Kingdom
$454K +$531K +6,778 New
RJFSA
42
Raymond James Financial Services Advisors
Florida
$437K -$4.62K -59 -0.9%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$428K +$39.9K +510 +9%
Barclays
44
Barclays
United Kingdom
$411K +$348K +4,441 +262%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$407K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$387K – – –
CS
47
Credit Suisse
Switzerland
$359K -$125K -1,600 -23%
Jane Street
48
Jane Street
New York
$327K +$327K +4,176 +589%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$318K +$97.1K +1,240 +35%
UBS AM
50
UBS AM
Illinois
$317K +$184K +2,353 +99%
1
2
3 4 5

TXMD Hedge Fund Activity: Q1 2021 in Review

160 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2021, worth a combined $237M — up 20% from $197M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TXMD positions and 24 closed out — a net gain of 3 holders — while 62 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $9.67M. The largest seller was GMT Capital, exiting entirely with an estimated $7.24M sold.

  • 160 institutional investors held TherapeuticsMD (TXMD) as of Q1 2021, up from 159 in Q4 2020.
  • Funds reported $237M of TherapeuticsMD stock for Q1 2021, up 20% quarter-over-quarter.
  • 27 funds opened new TherapeuticsMD positions in Q1 2021 and 24 closed out, a net change of +3 holders.
  • The largest TherapeuticsMD buyer in Q1 2021 was BlackRock, an estimated $9.67M added.
  • The largest TherapeuticsMD seller in Q1 2021 was GMT Capital, an estimated $7.24M sold.

Based on aggregated 13F filings for Q1 2021.